Scinovex
reviewTop 1% cited

Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early Pregnancy

Obstetrics and Gynecology · 2010 · Vol. 116(2) · pp. 402–414
Emmanuel BujoldStéphanie RobergeYves LacasseMarc BureauFrançois AudibertSylvie MarcouxJean Claude ForestYves Giguère

Abstract

Low-dose aspirin initiated in early pregnancy is an efficient method of reducing the incidence of preeclampsia and IUGR.

Pregnancy and preeclampsia studiesBirth, Development, and HealthMaternal and fetal healthcarePreeclampsiaAspirinIntrauterine growth restrictionPregnancyObstetricsMedicineGynecologyInternal medicineGestationBiology

MeSH terms

AspirinFemaleFetal Growth RetardationGestational AgeHumansPlatelet Aggregation InhibitorsPre-EclampsiaPregnancyIncidenceRandomized Controlled Trials as TopicPremature Birth
Citations
1,058
FWCI
51.76
field-weighted impact
References
89
Percentile
100%
vs. same field & year
Citations per year
Cited by
Hypertensive Disorders of Pregnancy
Hypertension · 2018 · 1,947 citations
ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy
Obstetrics and Gynecology · 2018 · 645 citations
ACOG Practice Bulletin No. 204: Fetal Growth Restriction
Obstetrics and Gynecology · 2019 · 557 citations
2013 ESH/ESC Guidelines for the management of arterial hypertension
European Heart Journal · 2013 · 13,652 citations
2013 ESH/ESC Guidelines for the management of arterial hypertension
Journal of Hypertension · 2013 · 5,659 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.